 Tower Research Capital LLC TRC lifted its position in shares of Madrigal Pharmaceuticals Inc NASDAQ:MDGL by 477.1 during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission SEC. The institutional investor owned 958 shares of the biopharmaceutical companys stock after acquiring an additional 792 shares during the quarter. Tower ... 